Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000875320-26-000219
Filing Date
2026-05-13
Accepted
2026-05-13 16:10:16
Documents
4
Effectiveness Date
2026-05-13

Document Format Files

Seq Description Document Type Size
1 S-8 POS s-8pos2013plan.htm S-8 POS 218813
2 EX-5.1 a2026s-8pos_ex51xopinion20.htm EX-5.1 9439
3 EX-23.1 a2013s-8pos_ex231xeyconsent.htm EX-23.1 3001
4 GRAPHIC image_0.jpg GRAPHIC 18735
  Complete submission text file 0000875320-26-000219.txt   258202
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-232948 | Film No.: 26973333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)